Funded startups/Resolute Science, Inc.
RS

Resolute Science, Inc.

SEC filing
Biotechnology · San Diego, CA
Form D on EDGAR
Amount raised$2.9Msold at filing
Total offering$4M$1.1M still open
Investors in the raise25count reported to the SEC
FiledApr 3, 2026first sale Feb 3, 2025

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

James MackayDirector
Andre BasbaumExecutive Officer, Director
Faith BarnettExecutive Officer, Director

Executive officers, directors and promoters as listed on the Form D.

Filing history

FormFiledAmount soldOffering
D/AApr 3, 2026$2.9M$4MEDGAR
DFeb 10, 2025$1.4M$3MEDGAR